The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes

被引：13

作者：

Cuculi, F. ^{[1
]}

Radovanovic, D. ^{[1
]}

Eberli, F. R. ^{[1
]}

Stauffer, J. C. ^{[1
]}

Bertel, O. ^{[1
]}

Erne, P. ^{[1
]}

机构：

[1] Kantonsspital Luzern, Dept Cardiol, CH-6000 Luzern, Switzerland

来源：

CARDIOLOGY | 2008年 / 109卷 / 03期

关键词：

acute coronary syndromes; statin therapy; presentation mode; AMIS project;

D O I：

10.1159/000106676

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: The role of statin use in the treatment of acute coronary syndromes (ACS) is not clear. The aim of our study was to evaluate the role of statins in ACS. Methods: Using data from the Acute Myocardial Infarction in Switzerland (AMIS Plus) Project, we compared the effects of chronic statin use, statin therapy after admission and no statin therapy on presentation mode and outcomes in ACS. Results: Available data from the period 2001-2006 including 11,603 patients were analyzed. Major cardiac event rates and in-hospital mortality were more common in statin-naive patients compared to patients who received statins. Conclusions: Our results support the importance of statin treatment in ACS. Chronic statin therapy seems to alter the initial presentation of ACS but it is questionable whether it provides an additional effect on early outcomes compared to the establishment of statin therapy after admission in statin-naive patients.

引用

页码：156 / 162

页数：7

共 23 条

[11] Statin and β-blocker therapy and the initial presentation of coronary heart disease
Go, AS
Iribarren, C
Chandra, M
Lathon, PV
Fortmann, SP
Quertermous, T
Hlatky, MA
[J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (04) : 229 - 238
[12] Withdrawal of statins increases event rates in patients with acute coronary syndromes
Heeschen, C
Hamm, CW
Laufs, U
Snapinn, S
Böhm, M
White, HD
[J]. CIRCULATION, 2002, 105 (12) : 1446 - 1452
[13] 3-HYDROXY-3-METHYLGLUTARYL - COENZYME-A REDUCTASE INHIBITORS IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
HOEG, JM
BREWER, HB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (24): : 3532 - 3536
[14] The effect of early, intensive statin therapy on acute coronary syndrome - A meta-analysis of randomized controlled trials
Hulten, Eddie
Jackson, Jeffrey L.
Douglas, Kevin
George, Susan
Villines, Todd C.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (17) : 1814 - 1821
[15] Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction
Iwakura, K
Ito, H
Kawano, S
Okamura, A
Kurotobi, T
Date, M
Inoue, K
Fujii, K
[J]. EUROPEAN HEART JOURNAL, 2006, 27 (05) : 534 - 539
[16] High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
Kinlay, S
Schwartz, GG
Olsson, AG
Rifai, N
Leslie, SJ
Sasiela, WJ
Szarek, M
Libby, P
Ganz, P
[J]. CIRCULATION, 2003, 108 (13) : 1560 - 1566
[17] Radovanovic Dragana, 2005, HeartDrug, V5, P131, DOI 10.1159/000085886
[18] Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
Schönbeck, U
Libby, P
[J]. CIRCULATION, 2004, 109 (21) : 18 - 26
[19] Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
Schwartz, GG
Olsson, AG
Ezekowitz, MD
Ganz, P
Oliver, MF
Waters, D
Zeiher, A
Chaitman, BR
Leslie, S
Stern, T
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13): : 1711 - 1718
[20] Association of statin therapy with outcomes of acute coronary syndromes: The GRACE Study
Spencer, FA
Allegrone, J
Goldberg, RJ
Gore, JM
Fox, KAA
Granger, CB
Mehta, RH
Brieger, D
[J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (11) : 857 - 866

← 1 2 3 →